These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1609297)

  • 1. Progress in chemotherapy for metastatic breast cancer.
    Sledge GW; Antman KH
    Semin Oncol; 1992 Jun; 19(3):317-32. PubMed ID: 1609297
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.
    Artac M; Koral L; Toy H; Guler T; Boruban MC; Altundag K
    J Oncol Pharm Pract; 2014 Apr; 20(2):141-5. PubMed ID: 23676508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.
    Bjelic-Radisic V; Stöger H; Winter R; Beham-Schmid C; Petru E
    Anticancer Res; 2006; 26(2B):1627-30. PubMed ID: 16619583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
    Myers SE; Mick R; Williams SF
    Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for breast cancer. Part 2: Treatment of metastatic breast cancer.
    Hill GJ
    W V Med J; 1986 Aug; 82(8):267-9. PubMed ID: 3463009
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined chemotherapy of metastatic cancer of the breast].
    Izmaĭlova GE; Letiagin VP; Starikova AB
    Sov Med; 1988; (4):91-4. PubMed ID: 3406828
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy regimens in metastatic breast cancer.
    Glück S
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):47-8. PubMed ID: 21326146
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer.
    Jäger C; Kafka A; Bossert S; Grundmann R; Windisch J; Kreienberg R; Heilmann V
    Anticancer Res; 2004; 24(5B):3209-14. PubMed ID: 15510612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow necrosis in a patient with metastatic breast cancer in chemotherapy with chlorambucil, methotrexate and prednisone].
    Voigtmann R
    Onkologie; 1989 Feb; 12(1):36-8, 40. PubMed ID: 2541386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Questions on hormone and chemotherapy in metastatic breast cancer].
    Brunner KW
    Gynakol Rundsch; 1988; 28 Suppl 1():76-83. PubMed ID: 3042537
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
    Peters WP
    Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Bone Marrow Carcinomatosis Arising from Breast Cancer - A Case Report].
    Nakayama I
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1391-1392. PubMed ID: 29394644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow toxicity of chemotherapy combinations in operable carcinoma of the breast].
    Mano MP; Barengo R; Sinistrero G; Giurgola L; Sismondi P
    Minerva Ginecol; 1985 Jun; 37(6):335-8. PubMed ID: 4034081
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].
    Petru E; Schmähl D
    Dtsch Med Wochenschr; 1987 Feb; 112(7):270-5. PubMed ID: 3545749
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors related to response to chemotherapy in metastatic breast cancer.
    J Clin Oncol; 1989 Mar; 7(3):403-4. PubMed ID: 2918336
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpretation of results of chemotherapy trials in metastatic breast cancer.
    J Clin Oncol; 1986 Feb; 4(2):258-61. PubMed ID: 3511185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
    Jouve M; Palangie T; Bretaudeau B; Garcia-Giralt E; Asselain B; Magdelenat H; Pouillart P
    Bull Cancer; 1984; 71(2):148. PubMed ID: 6733294
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cancer chemotherapy based on evidence--metastatic breast cancer].
    Takashima S; Saeki T; Ohsumi S
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):44-51. PubMed ID: 10660732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
    O'Shaughnessy JA; Cowan KH; Nienhuis AW; McDonagh KT; Sorrentino BP; Dunbar CE; Chiang Y; Wilson W; Goldspiel B; Kohler D
    Hum Gene Ther; 1994 Jul; 5(7):891-911. PubMed ID: 7526902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow toxicity of the chemotherapy of gynecological tumors].
    Sismondi P; Giai M; Mano MP; Catolla Cavalcanti T; Lamberto A
    Minerva Ginecol; 1985; 37(1-2):27-30. PubMed ID: 4011025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.